Works matching IS 09024441 AND DT 2024 AND VI 112 AND IP 1

Results: 16

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 51, doi. 10.1111/ejh.14132
By:
- Gupta, Supriya;
- Kohorst, Mira;
- Alkhateeb, Hassan B.
Publication type:
Article
Chimeric antigen receptor T‐cell therapy, where are we now and where are we heading for.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 4, doi. 10.1111/ejh.14123
By:
- Wang, Liang;
- Mei, Heng
Publication type:
Article
Tandem bispecific CD123/CLL‐1 CAR‐T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 83, doi. 10.1111/ejh.14104
By:
- Wang, Xiang‐Yu;
- Bian, Mei‐Ru;
- Lin, Guo‐Qiang;
- Yu, Lei;
- Zhang, Yan‐Ming;
- Wu, De‐Pei
Publication type:
Article
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 122, doi. 10.1111/ejh.14102
By:
- Chatterjee, Gaurav;
- Dhende, Priyanka;
- Raj, Simpy;
- Shetty, Vruksha;
- Ghogale, Sitaram;
- Deshpande, Nilesh;
- Girase, Karishma;
- Patil, Jagruti;
- Kalra, Aastha;
- Narula, Gaurav;
- Dalvi, Kajal;
- Dhamne, Chetan;
- Moulik, Nirmalya Roy;
- Rajpal, Sweta;
- Patkar, Nikhil V.;
- Banavali, Shripad;
- Gujral, Sumeet;
- Subramanian, Papagudi G.;
- Tembhare, Prashant R.
Publication type:
Article
Long‐term survivorship care after CAR‐T cell therapy.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 41, doi. 10.1111/ejh.14100
By:
- Puckrin, Robert;
- Jamani, Kareem;
- Jimenez‐Zepeda, Victor H.
Publication type:
Article
Adverse events and efficacy of second‐round CAR‐T cell therapy in relapsed pediatric B‐ALL.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 75, doi. 10.1111/ejh.14092
By:
- Ji, Qi;
- Wu, Xiaochen;
- Zhang, Yongping;
- Zeng, Liang;
- Dong, Yi;
- Liu, Ruiqing;
- Li, Bohan;
- Bai, Zhenjiang;
- Hu, Shaoyan;
- Lu, Jun;
- Wu, Shuiyan
Publication type:
Article
Enhanced efficacy of CD19/CD22 bispecific CAR‐T cells with EAAAK linker on B‐cell malignancies.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 64, doi. 10.1111/ejh.14090
By:
- Ma, Renyuxue;
- You, Fengtao;
- Tian, Shuaiyu;
- Zhang, Tingting;
- Tian, Xiaopeng;
- Xiang, Shufen;
- Wu, Hai;
- Yang, Nan;
- An, Gangli;
- Yang, Lin
Publication type:
Article
Donor‐derived stem cell infusion for sustained pancytopenia after CD19 CAR‐T therapy for relapsed patients post allogeneic stem cell transplantation.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 94, doi. 10.1111/ejh.14050
By:
- Li, Yingying;
- Li, Yixue;
- Zhang, Mingming;
- Zhao, Houli;
- Zhu, Miaoyong;
- Huang, He;
- Hu, Yongxian
Publication type:
Article
Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T‐cell therapy.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 102, doi. 10.1111/ejh.14088
By:
- Patel, Nikita P.;
- Dalal, Prarthana J.;
- Meng, Zhiying;
- Baldridge, Abigail S.;
- Cascino, Gregory J.;
- Sunderraj, Ashwin;
- Sinha, Arjun;
- Karmali, Reem;
- Feinstein, Matthew J.;
- Akhter, Nausheen
Publication type:
Article
CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 6, doi. 10.1111/ejh.14076
By:
- Khan, Aalia N.;
- Asija, Sweety;
- Pendhari, Juber;
- Purwar, Rahul
Publication type:
Article
Apheresis collection of mononuclear cells for chimeric‐antigen receptor therapies.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 36, doi. 10.1111/ejh.14071
By:
- Maitta, Robert W.
Publication type:
Article
Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor‐T cell therapy.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 111, doi. 10.1111/ejh.14068
By:
- Yeung, Cecilia C. S.;
- Woolston, David W.;
- Wu, Vicky;
- Voutsinas, Jenna M.;
- Basom, Ryan;
- Davis, Chris;
- Hirayama, Alexandre V.;
- Naresh, Kikkeri N.
Publication type:
Article
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 19, doi. 10.1111/ejh.14051
By:
- Fischer, Luise;
- Grieb, Nora;
- Platzbecker, Uwe;
- Vucinic, Vladan;
- Merz, Maximilian
Publication type:
Article
Case Report: CAR‐T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation.
Published in:
2024
By:
- Canale, Filippo Antonio;
- Pitea, Martina;
- Alati, Caterina;
- Porto, Gaetana;
- Pratico, Giulia;
- Utano, Giovanna;
- Germanò, Jessyca;
- Imbalzano, Lucrezia;
- Ferreri, Anna;
- Verduci, Chiara;
- Santoro, Ludovica;
- Policastro, Giorgia;
- Loteta, Barbara;
- Pugliese, Marta;
- Martino, Massimo
Publication type:
Case Study
Chimeric antigen receptor T cells for acute myeloid leukemia.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 28, doi. 10.1111/ejh.14047
By:
- Fetsch, Viktor;
- Zeiser, Robert
Publication type:
Article
Issue Information.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 1, doi. 10.1111/ejh.13994
Publication type:
Article